Mishra Dhatu Nigam Ltd Q1 FY27 Results

MIDHANI's consolidated Q1 FY27 PAT rose 27.0% YoY to ₹16.47 Cr (standalone ₹16.31 Cr, +27.4% YoY per the company's own press release) on consolidated revenue of ₹239.49 Cr, up 40.5% YoY — both metrics running ahead of management's guided pace of 15% revenue and 20% PAT growth over the next two years. Even so, the quarter fell short of the pre-result Street-implied revenue range of ₹300-350 Cr, landing roughly 20-30% below the low end despite the strong YoY jump; EBITDA of ₹46.60 Cr (+12.9% YoY) translated to a margin of ~19.5% on a press-release basis, at the low end of the ~19-21% range flagged pre-result. No formal third-party Street consensus specific to this quarter turned up in search, so the read here leans on our own pre-result preview and management's own guidance.

The real story is margin, not growth. Operating margin (EBITDA less other income, over revenue from operations) compressed to ~15.3% from ~20.0% a year ago and ~21.0% last quarter, while net margin fell to 6.6% of total income from 7.3% YoY — well short of management's own 24-25% FY27 EBITDA margin target. The squeeze sits on the cost side: total expenses grew 42.2% YoY to ₹225.56 Cr, outpacing 40.5% revenue growth, with employee costs up 15.8% YoY and other expenses up 13.9% YoY as the key drivers, alongside a swing in the inventory-change line (₹-20.87 Cr this quarter vs ₹-70.80 Cr a year ago). QoQ, both revenue (-56.7%) and PAT (-78.9%) fell sharply from Q4 FY26 (₹552.75 Cr revenue, ₹77.90 Cr PAT), but Q4 is a seasonally loaded quarter for this PSU (year-end execution and billing), so the sequential drop reads as seasonal, not deterioration.

The stock went into the print at ₹421.2, up 1.1% over the past month of trading.

Order book stood at ₹2,329 Cr as of July 1, 2026, roughly in line with the ₹2,290 Cr flagged in our pre-result preview and tracking management's stated aim of ~₹1,500 Cr in fresh FY26-27 bookings. No exceptional items appear in either the current or year-ago quarter, so the growth print is clean with no one-off distortion, and the consolidated result includes only a ₹0.15 Cr equity-method profit share from the pre-operational Utkarsha Aluminium JV, keeping standalone and consolidated numbers within 1% of each other. Going into Q2, the margin trajectory against the 24-25% FY27 target — not the topline growth rate, which is already running ahead of guidance — is the metric to watch.

Q1 delivered strong 40.5% YoY revenue and 27% PAT growth against a solid ₹2,329 Cr order book, but EBITDA margin collapsed to 19.4% vs 24-25% prior guidance—a ~500 bps miss attributed to LPG crisis and raw material volatility. Management expects recovery from Q3, but the sequential 78.9% PAT decline and fixed-price defense contract exposure create near-term downside risk if commodity headwinds persist.

Analysts pressed hard on margin recovery credibility, 40% growth sustainability, and capex timing. Management hedged on all three. CFO candid that margin recovery is 'hope' for Q3, not certainty. Directors clarified 40% not annual run-rate; capex approval timeline opaque. Overall: rigorous Q&A; management held ground but did not commit to specific recovery numbers.

Score 7/10. Candid on challenges (LPG crisis, RM volatility, margin compression, nomination order loss). Transparent on limitations (capex timeline unknown, S400 revenue 'probably 2-3 quarters later'). Some hedging on recovery timing ('hope' for Q3 normalization) and capex approval (cannot commit). Revenue track record solid: beat 15% FY26 guidance with 40.5%. PAT growth 27% tracking 20% 2-year target. Margin delivery weak: 19.4% vs 24-25% guidance (-550 bps miss). Scrap inventory management effective (₹75 Cr reduction). Certifications on track (S400 done, Nadcap by end-FY27).

MIDHANI reports Q1 FY27 results on August 12, with a robust order book (₹2,290 cr) and 20% full-year revenue guidance anchoring expectations. Yet the Street's near-term debate centers on margins: Q4 FY26 saw EBITDA margins compress 222 bps to 19.8% due to raw material cost inflation and a less favorable product mix. The key question for Q1 is whether cost pressures have stabilized—and whether the company can steer toward higher-margin special alloys ahead of its ₹1,000 cr capex ramp.

A strong Q1 would show revenue in the upper half of ₹300–350 Cr with EBITDA margins stable or rising on favorable mix (higher-value superalloys, titanium specialties). PAT growth should exceed 15% YoY. A weak Q1 would print below ₹300 Cr revenue or margins sub-19%, signaling prolonged cost headwinds or order execution delays. The Street looks for capex progress updates (automation, titanium, single-crystal blade materials).

MIDHANI has delivered steady order inflows despite defence capex cycles, and FY26 revenues rose 12.5% (to ~₹1,209 Cr) with PAT up 19%. However, margins lagged: EBITDA growth (10.7%) trailed revenue, indicating cost pressures are real. The company's FY27 guidance (20% revenue growth) is ambitious; if realised, it would mark an acceleration. The capex ramp (₹1,000 Cr over 3 years) is the vehicle for margin recovery—but payoff is medium-term (FY27–FY28). Q1 will be watched for evidence that the company is managing input costs and shifting product mix upward.

Aug 1: GM (Production) Shri Anand Kumar Kaluvala retired. Routine transition in a PSU; no operational impact flagged. Jun 5: New Government Nominee Director appointed (Shri Prakash Rajpurohit replaces Shri Amit Satija). Board composition change in line with government shareholding rights. May 29: FY26 final results approved; ₹1.25 dividend per share recommended (12.5% payout). Strong capital return posture. May 27: Regulatory fine (₹4.95L each, BSE and NSE) for Q4 FY26 board composition non-compliance under SEBI LODR. Non-material; company has not yet paid. Jun 25: Trading window closed for Q1 FY27 results (standard SEBI compliance). Summary: Routine governance and compliance events; no material business risk or opportunity flagged in recent filings.